抗逆转录病毒药物在淋巴结中的暴露是不均匀的,且依赖于药物。
Antiretroviral drug exposure in lymph nodes is heterogeneous and drug dependent.
机构信息
Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.
出版信息
J Int AIDS Soc. 2022 Apr;25(4):e25895. doi: 10.1002/jia2.25895.
INTRODUCTION
HIV reservoirs and infected cells may persist in tissues with low concentrations of antiretrovirals (ARVs). Traditional pharmacology methods cannot assess variability in ARV concentrations within morphologically complex tissues, such as lymph nodes (LNs). We evaluated the distribution of six ARVs into LNs and the proximity of these ARVs to CD4 T cells and cell-associated RT-SHIV viral RNA.
METHODS
Between December 2014 and April 2017, RT-SHIV infected (SHIV+; N = 6) and healthy (SHIV-; N = 6) male rhesus macaques received two selected four-drug combinations of six ARVs over 10 days to attain steady-state conditions. Serial cryosections of axillary LN were analysed by a multimodal imaging approach that combined mass spectrometry imaging (MSI) for ARV disposition, RNAscope in situ hybridization for viral RNA (vRNA) and immunohistochemistry for CD4 T cell and collagen expression. Spatial relationships across these four imaging domains were investigated by nearest neighbour search on co-registered images using MATLAB.
RESULTS
Through MSI, ARV-dependent, heterogeneous concentrations were observed in different morphological LN regions, such as the follicles and medullary sinuses. After 5-6 weeks of infection, more limited ARV penetration into LN tissue relative to the blood marker heme was found in SHIV+ animals (SHIV+: 0.7 [0.2-1.4] mm; SHIV-: 1.3 [0.5-1.7] mm), suggesting alterations in the microcirculation. However, we found no detectable increase in collagen deposition. Regimen-wide maps of composite ARV distribution indicated that up to 27% of SHIV+ LN tissue area was not exposed to detectable ARVs. Regions associated with B cell follicles had median 1.15 [0.94-2.69] -fold reduction in areas with measurable drug, though differences were only statistically significant for tenofovir (p = 0.03). Median co-localization of drug with CD4 target cells and vRNA varied widely by ARV (5.1-100%), but nearest neighbour analysis indicated that up to 10% of target cells and cell-associated vRNA were not directly contiguous to at least one drug at concentrations greater than the IC50 value.
CONCLUSIONS
Our investigation of the spatial distributions of drug, virus and target cells underscores the influence of location and microenvironment within LN, where a small population of T cells may remain vulnerable to infection and low-level viral replication during suppressive ART.
简介
HIV 储库和受感染的细胞可能存在于抗逆转录病毒药物(ARV)浓度较低的组织中。传统的药理学方法无法评估形态复杂的组织(如淋巴结(LN))中 ARV 浓度的变化。我们评估了六种 ARV 进入 LN 的分布情况,以及这些 ARV 与 CD4 T 细胞和细胞相关 RT-SHIV 病毒 RNA 的接近程度。
方法
2014 年 12 月至 2017 年 4 月,接受过 RT-SHIV 感染(SHIV+;N=6)和健康(SHIV-;N=6)的雄性恒河猴接受了两种选定的六药四联组合,每天服用 10 天,以达到稳态条件。采用多模态成像方法分析腋窝 LN 的连续冷冻切片,该方法将质谱成像(MSI)用于 ARV 分布、RNAscope 原位杂交用于病毒 RNA(vRNA)和免疫组织化学用于 CD4 T 细胞和胶原表达。使用 MATLAB 在配准图像上进行最近邻搜索,研究了这四个成像域之间的空间关系。
结果
通过 MSI,观察到不同形态 LN 区域(如滤泡和髓窦)存在 ARV 依赖性、不均匀的浓度。在感染后 5-6 周,与血液标志物血红素相比,SHIV+动物中发现 ARV 进入 LN 组织的程度受到限制(SHIV+:0.7[0.2-1.4]mm;SHIV-:1.3[0.5-1.7]mm),这表明微循环发生了改变。然而,我们没有发现胶原沉积的可检测增加。综合 ARV 分布的方案范围图表明,高达 27%的 SHIV+LN 组织区域未暴露于可检测到的 ARV 药物。与 B 细胞滤泡相关的区域中,药物可测量的药物面积中位数降低了 1.15[0.94-2.69]倍,尽管替诺福韦的差异仅具有统计学意义(p=0.03)。药物与 CD4 靶细胞和 vRNA 的共定位中位数差异很大(5.1-100%),但最近邻分析表明,高达 10%的靶细胞和细胞相关 vRNA 与至少一种药物的浓度大于 IC50 值时没有直接相邻。
结论
我们对药物、病毒和靶细胞的空间分布的研究强调了 LN 内位置和微环境的影响,在抑制性 ART 期间,一小部分 T 细胞可能仍然容易受到感染和低水平病毒复制的影响。